Metoprolol Succinate Tablet, Extended Release
Product Images NDC 51655-239

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 239 52 Rev A 03 23)

Label (51655 239 52 Rev A 03 23)
Label for Metoprolol Succinate Extended-Release Tablets, USP 25 mg, bottle of 30 tablets. The label includes storage instructions, dosage reminder to see package insert, and states Rx only. Manufactured or repackaged by Northwind Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

Picture-1 (Picture 1)

Picture-1 (Picture 1)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for various subgroups comparing metoprolol succinate extended release tablets versus placebo. The chart covers outcomes including total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, with multiple subgroup categories listed on the vertical axis and risk ratios on the horizontal axis.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of metoprolol succinate showing the molecular formula with its functional groups and the succinate moiety. The structure includes aromatic rings and side chains characteristic of metoprolol succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.